Development
Zeo ScientifiX, Inc.
ZEOX
$1.96
-$0.01-0.51%
OTC PK
| 10/31/2023 | 07/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 16.48% | 44.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.48% | 44.38% | |||
| Cost of Revenue | -18.11% | 50.14% | |||
| Gross Profit | 21.80% | 43.52% | |||
| SG&A Expenses | -3.72% | -5.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.60% | -3.30% | |||
| Operating Income | 22.39% | 24.38% | |||
| Income Before Tax | 32.56% | 18.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.56% | 18.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.56% | 18.76% | |||
| EBIT | 22.39% | 24.38% | |||
| EBITDA | 14.16% | 26.64% | |||
| EPS Basic | 31.88% | 16.93% | |||
| Normalized Basic EPS | 23.68% | 16.93% | |||
| EPS Diluted | 31.88% | 16.93% | |||
| Normalized Diluted EPS | 23.68% | 16.93% | |||
| Average Basic Shares Outstanding | -0.99% | -2.23% | |||
| Average Diluted Shares Outstanding | -0.99% | -2.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||